Arabic Arabic English English French French German German
dark

Cardior Raises €64M Series B to Advance Clinical Pipeline of RNA Therapeutics to Treat Cardiac Disease

Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA -based therapeutics for patients with cardiac diseases, announced the closing of a €64 million Series B financing round. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

MassBio Industry Snapshot Predicts 40,000 New Biopharma Jobs Over the Next 10 Years

Next Post

Rapid Dose Therapeutics Reports Fiscal Year 2021 Financial Results

Related Posts
Total
0
Share